Skip to main content
. 2021 Jun 30;21:757. doi: 10.1186/s12885-021-08415-1

Table 1.

Patient characteristics, median waiting time with interquartile interval from date of diagnosis to treatment and the proportion treated with surgery, radiotherapy or systemic anticancer treatment, among colorectal cancer patients diagnosed in 2015–2016 in Norway

All Surgery Radiotherapy Systemic Anticancer Treatment
N (%) N (%) p50 [p25, p75] % treated N (%) p50 [p25, p75] % treated N (%) p50 [p25, p75] % treated
Cancer type
 Colon 5677 (69.1%) 4672 (76.5%) 15.0 [3.0, 24.0] 82.3% 31 (4.5%) 34.0 [20.0, 53.0] 0.5% 449 (63.9%) 24.0 [15.0, 37.0] 7.9%
 Rectal 2539 (30.9%) 1433 (23.5%) 25.0 [14.0, 35.0] 56.4% 664 (95.5%) 33.0 [27.0, 41.0] 26.2% 254 (36.1%) 27.0 [19.0, 38.0] 10.0%
Year of diagnosis
 2015 4114 (50.1%) 3074 (50.4%) 16.0 [4.0, 27.0] 74.7% 352 (50.6%) 34.0 [27.0, 41.0] 8.6% 328 (46.7%) 23.0 [16.0, 36.0] 8.0%
 2016 4102 (49.9%) 3031 (49.6%) 17.0 [6.0, 27.0] 73.9% 343 (49.4%) 32.0 [26.0, 40.0] 8.4% 375 (53.3%) 26.0 [18.0, 38.0] 9.1%
Age group
 18–49 485 (5.9%) 343 (5.6%) 11.0 [0.0, 22.0] 70.7% 56 (8.1%) 29.5 [24.5, 38.0] 11.5% 60 (8.5%) 20.5 [17.0, 27.0] 12.4%
 50–59 904 (11.0%) 609 (10.0%) 16.0 [2.0, 28.0] 67.4% 131 (18.8%) 33.0 [26.0, 40.0] 14.5% 135 (19.2%) 23.0 [16.0, 32.0] 14.9%
 60–69 2098 (25.5%) 1535 (25.1%) 17.0 [4.0, 28.0] 73.2% 222 (31.9%) 33.0 [27.0, 42.0] 10.6% 258 (36.7%) 25.0 [17.0, 38.0] 12.3%
 70–79 2629 (32.0%) 2095 (34.3%) 17.0 [8.0, 27.0] 79.7% 169 (24.3%) 34.0 [28.0, 42.0] 6.4% 209 (29.7%) 28.0 [19.0, 41.0] 7.9%
 80–89 1790 (21.8%) 1361 (22.3%) 17.0 [7.0, 27.0] 76.0% 99 (14.2%) 33.0 [27.0, 41.0] 5.5% 41 (5.8%) 26.0 [15.0, 47.0] 2.3%
 90+ 310 (3.8%) 162 (2.7%) 12.0 [0.0, 25.0] 52.3% 18 (2.6%) 30.5 [23.0, 38.0] 5.8% 0 (0.0%) 0.0%
Sex
 Female 4018 (48.9%) 3069 (50.3%) 15.0 [4.0, 26.0] 76.4% 282 (40.6%) 33.5 [26.0, 40.0] 7.0% 296 (42.1%) 24.0 [15.0, 38.5] 7.4%
 Male 4198 (51.1%) 3036 (49.7%) 18.0 [6.0, 28.0] 72.3% 413 (59.4%) 33.0 [27.0, 41.0] 9.8% 407 (57.9%) 25.0 [18.0, 36.0] 9.7%
Stage
 Localised 1767 (21.5%) 1670 (27.4%) 16.0 [0.0, 29.0] 94.5% 46 (6.6%) 32.0 [24.0, 38.0] 2.6% 5 (0.7%) 41.0 [17.0, 62.0] 0.3%
 Regional 4118 (50.1%) 3587 (58.8%) 17.0 [9.0, 27.0] 87.1% 393 (56.5%) 33.0 [27.0, 40.0] 9.5% 74 (10.5%) 26.0 [17.0, 37.0] 1.8%
 Metastasis 1716 (20.9%) 821 (13.4%) 13.0 [1.0, 24.0] 47.8% 143 (20.6%) 34.0 [25.0, 45.0] 8.3% 463 (65.9%) 25.0 [16.0, 36.0] 27.0%
 Unknown 615 (7.5%) 27 (0.4%) 0.0 [0.0, 132.0] 4.4% 113 (16.3%) 34.0 [27.0, 42.0] 18.4% 161 (22.9%) 26.0 [18.0, 38.0] 26.2%
Marital status
 Single 3650 (44.4%) 2655 (43.5%) 16.0 [3.0, 27.0] 72.7% 298 (42.9%) 34.0 [26.0, 41.0] 8.2% 262 (37.3%) 26.5 [19.0, 40.0] 7.2%
 Married 4566 (55.6%) 3450 (56.5%) 17.0 [7.0, 27.0] 75.6% 397 (57.1%) 33.0 [27.0, 40.0] 8.7% 441 (62.7%) 24.0 [16.0, 35.0] 9.7%
Income
 Low 1106 (13.5%) 816 (13.4%) 15.0 [3.0, 27.0] 73.8% 84 (12.1%) 31.0 [26.5, 38.5] 7.6% 77 (11.0%) 27.0 [17.0, 39.0] 7.0%
 Intermediate 5155 (62.7%) 3846 (63.0%) 17.0 [6.0, 27.0] 74.6% 422 (60.7%) 34.0 [27.0, 42.0] 8.2% 389 (55.3%) 26.0 [18.0, 39.0] 7.5%
 High 1955 (23.8%) 1443 (23.6%) 16.0 [4.0, 28.0] 73.8% 189 (27.2%) 33.0 [25.0, 39.0] 9.7% 237 (33.7%) 24.0 [15.0, 34.0] 12.1%
Education
 Low 2503 (30.5%) 1830 (30.0%) 16.0 [5.0, 27.0] 73.1% 198 (28.5%) 33.0 [27.0, 41.0] 7.9% 175 (24.9%) 25.0 [18.0, 38.0] 7.0%
 Intermediate 3926 (47.8%) 2899 (47.5%) 17.0 [6.0, 27.0] 73.8% 370 (53.2%) 34.0 [27.0, 42.0] 9.4% 329 (46.8%) 25.0 [17.0, 37.0] 8.4%
 High 1787 (21.8%) 1376 (22.5%) 16.0 [3.0, 27.0] 77.0% 127 (18.3%) 31.0 [22.0, 39.0] 7.1% 199 (28.3%) 25.0 [15.0, 38.0] 11.1%
Region
 Southern and Eastern Norway 4411 (53.7%) 3349 (54.9%) 17.0 [5.0, 27.0] 75.9% 334 (48.1%) 37.0 [30.0, 47.0] 7.6% 360 (51.2%) 27.0 [18.0, 39.0] 8.2%
 Western Norway 1750 (21.3%) 1229 (20.1%) 16.0 [5.0, 28.0] 70.2% 155 (22.3%) 31.0 [26.0, 37.0] 8.9% 200 (28.4%) 21.0 [14.0, 33.5] 11.4%
 Central Norway 1220 (14.8%) 915 (15.0%) 15.0 [6.0, 25.0] 75.0% 116 (16.7%) 26.5 [19.0, 34.5] 9.5% 90 (12.8%) 23.0 [15.0, 33.0] 7.4%
 Northern Norway 835 (10.2%) 612 (10.0%) 17.0 [4.0, 30.0] 73.3% 90 (12.9%) 32.5 [27.0, 41.0] 10.8% 53 (7.5%) 30.0 [20.0, 47.0] 6.3%
Comorbidity
 No admissions 309 (3.8%) 230 (3.8%) 22.0 [12.0, 33.0] 74.4% 31 (4.5%) 39.0 [31.0, 55.0] 10.0% 35 (5.0%) 30.0 [21.0, 43.0] 11.3%
 0 5926 (72.1%) 4395 (72.0%) 16.0 [6.0, 27.0] 74.2% 542 (78.0%) 33.0 [27.0, 40.0] 9.1% 555 (78.9%) 25.0 [17.0, 36.0] 9.4%
 1–2 1671 (20.3%) 1266 (20.7%) 15.0 [3.0, 27.0] 75.8% 105 (15.1%) 32.0 [26.0, 43.0] 6.3% 108 (15.4%) 25.0 [16.0, 41.0] 6.5%
 3+ 310 (3.8%) 214 (3.5%) 17.0 [3.0, 28.0] 69.0% 17 (2.4%) 31.0 [27.0, 40.0] 5.5% 5 (0.7%) 34.0 [33.0, 44.0] 1.6%
Emergency Presentation
 No 5813 (70.8%) 4455 (73.0%) 19.0 [11.0, 29.0] 76.6% 583 (83.9%) 34.0 [27.0, 41.0] 10.0% 450 (64.0%) 27.0 [19.0, 39.0] 7.7%
 Yes 2403 (29.2%) 1650 (27.0%) 7.0 [0.0, 19.0] 68.7% 112 (16.1%) 29.5 [21.0, 38.5] 4.7% 253 (36.0%) 21.0 [14.0, 34.0] 10.5%
CPP
 No 1519 (18.5%) 1043 (17.1%) 1.0 [0.0, 18.0] 68.7% 40 (5.8%) 32.5 [24.0, 41.5] 2.6% 132 (18.8%) 21.0 [14.0, 34.0] 8.7%
 Yes 6697 (81.5%) 5062 (82.9%) 18.0 [10.0, 28.0] 75.6% 655 (94.2%) 33.0 [27.0, 41.0] 9.8% 571 (81.2%) 26.0 [18.0, 38.0] 8.5%